Regular Plan · IDCW Option · Large & Mid Cap · Scheme code 130497
NAV₹34.7780as on 24 Sep 2026
Fund houseHDFC Mutual Fund
CategoryLarge & Mid Cap
Plan & optionRegular · IDCW Option
History12.2 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
-3.26
-0.38
9.88
-8.03
3.99
7.62
10.35
4.89
3.41
Nifty LargeMidcap 250 benchmark
-4.60
-7.94
-2.03
-7.04
8.54
—
—
—
10.32
Large & Mid Cap category median
—
—
—
2.36
11.90
10.58
—
13.36
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
18.7%
-0.13
-0.17
0.93
-2.33%
-60.6%
80.75
Nifty LargeMidcap 250 benchmark
14.9%
0.14
0.19
—
—
-18.9%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
57 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
553
-44.3%
0.3%
78.1%
50%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
87%
93%
0.90
7.1%
-0.37
1.21
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 57 months this scheme and
Nifty LargeMidcap 250 share.
HDFC Large & Mid Cap Fund
Regular Plan · IDCW Option
Allocation
By asset
Equity
99.09%
Cash & Equivalents
0.45%
REITs / InvITs
0.34%
ETF Units
0.12%
By market cap
Large Cap
87.75%
Mid Cap
79.36%
Small Cap
31.52%
Unclassified
0.30%
Concentration
Number of stocks
242
Top 5 stocks
12.38%
Top 10 stocks
19.27%
Top 20 stocks
31.15%
Lines in the filing
244
Largest holding
3.79%
Largest sector
Banks 16.93%
Effective stocks
105.8
Sectors held
44
Cash
0.45%
Effective stocks is what the concentration works out to: a fund holding
242 names but most of its money in a few
behaves like a fund of 106. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Banks
16.93%
Pharmaceuticals & Biotechnology
11.61%
Finance
8.15%
IT - Software
6.57%
Auto Components
4.47%
Automobiles
3.86%
Retailing
3.58%
Insurance
3.03%
Petroleum Products
2.71%
Realty
2.63%
Healthcare Services
2.58%
Chemicals & Petrochemicals
2.54%
Telecom - Services
2.44%
Power
2.37%
Consumer Durables
2.01%
Ferrous Metals
1.84%
Agricultural, Commercial & Construction Vehicles
1.80%
Electrical Equipment
1.65%
Capital Markets
1.62%
Construction
1.51%
HDFC Large & Mid Cap Fund
Regular Plan · IDCW Option · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
ICICI Bank Ltd.
Banks
7,900,836
1,149
3.79%
2
HDFC Bank Ltd.
Banks
14,664,794
1,040
3.43%
3
Axis Bank Ltd.
Banks
4,550,000
592
1.95%
4
Bharti Airtel Ltd.
Telecom - Services
2,906,378
527
1.74%
5
State Bank of India
Banks
4,210,091
446
1.47%
6
Reliance Industries Ltd.
Petroleum Products
3,426,186
438
1.44%
7
Fortis Healthcare Limited
Healthcare Services
4,733,349
429
1.42%
8
Max Financial Services Ltd.
Insurance
2,602,017
409
1.35%
9
Prestige Estates Projects Ltd.
Realty
2,500,000
408
1.35%
10
Gland Pharma Ltd.
Pharmaceuticals & Biotechnology
1,400,000
404
1.33%
11
Maruti Suzuki India Limited
Automobiles
293,447
398
1.31%
12
Indusind Bank Ltd.
Banks
3,767,539
383
1.26%
13
MphasiS Limited.
IT - Software
1,537,999
373
1.23%
14
Aurobindo Pharma Ltd.
Pharmaceuticals & Biotechnology
2,160,032
371
1.22%
15
Mahindra & Mahindra Financial Services Ltd.
Finance
9,829,103
367
1.21%
16
Shriram Finance Ltd.
Finance
3,218,280
357
1.18%
17
Kotak Mahindra Bank Limited
Banks
8,413,845
353
1.16%
18
Eternal Limited
Retailing
10,354,959
340
1.12%
19
Infosys Limited
IT - Software
3,000,000
340
1.12%
20
Ajanta Pharma Limited
Pharmaceuticals & Biotechnology
897,224
323
1.07%
21
Lupin Ltd.
Pharmaceuticals & Biotechnology
1,400,000
306
1.01%
22
Larsen and Toubro Ltd.
Construction
730,535
295
0.98%
23
Bharat Forge Ltd.
Auto Components
1,350,110
284
0.94%
24
Ipca Laboratories Ltd.
Pharmaceuticals & Biotechnology
1,408,766
278
0.92%
25
Coforge Limited
IT - Software
1,382,005
274
0.91%
26
Eicher Motors Ltd.
Automobiles
348,452
277
0.91%
27
Bajaj Finance Ltd.
Finance
2,552,440
270
0.89%
28
Hindustan Petroleum Corp. Ltd.
Petroleum Products
7,311,414
267
0.88%
29
Glenmark Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
1,048,046
260
0.86%
30
Balkrishna Industries Ltd.
Auto Components
1,124,905
256
0.85%
HDFC Large & Mid Cap Fund
Regular Plan · IDCW Option · where the money sits
What the manager did last month
Between the filings of 30 Jun 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹124 cr
₹27 cr
2
0
+3.05%
Stock
Shares traded
Shares
Price
Value ₹ cr
New position
Diamond Power Infrastructure Limited
1,545,714
entered
—
50.1
GSPL Transmission Limited
311,846
entered
—
4.7
Added to
Biocon Ltd.
2,044,548
+204.5%
+1.8%
87.0
Axis Bank Ltd.
300,000
+7.1%
-8.6%
36.9
Trimmed
Infosys Limited
231,484
-7.2%
+13.0%
26.2
Kajaria Ceramics Ltd.
7,694
-2.3%
-1.0%
0.9
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹677,407
₹77,407
4.80%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 25 Sep 2026.